<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270335</url>
  </required_header>
  <id_info>
    <org_study_id>2005-005400-17</org_study_id>
    <secondary_id>GCP-2005-087</secondary_id>
    <secondary_id>KF 02 284302</secondary_id>
    <nct_id>NCT00270335</nct_id>
  </id_info>
  <brief_title>Optimizing Propofol in Obese Patients</brief_title>
  <official_title>Optimizing Propofol in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An accurate dosage of anesthetics during surgery is important. Usually this is achieved
      through close observation of the patient, but a new monitor (CSM-monitor) can measure the
      level of anesthesia more closely.

      In obese patients dosage of drugs is difficult due to the change in body composition. The
      CSM-monitor may provide a more accurate dosage of propofol (an anesthetic agent) during
      surgery, and as a consequence of that, also reduce the postoperative need for analgesics.

      Main objective: To optimise propofol dosing in obese patients undergoing hysterectomy.

      Main hypothesis: Monitoring the depth of anesthesia using the CSM-monitor reduces time to
      opening eyes in obese patients after hysterectomy in propofol anesthesia.

      Secondary hypotheses: CSM-monitoring reduce propofol dose in obese patients undergoing
      hysterectomy. Patients with a high CSM-level during hysterectomy have higher postoperative
      consumption of analgesics. Supplementary, an algorithm for the dose of propofol that most
      frequently results in a CSM-level between 40 and 60 is calculated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to opening eyes in obese patients after hysterectomy in propofol anaesthesia.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Propofol dose in obese patients undergoing hysterectomy.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative consumption of analgesics.</measure>
    <time_frame>24 h after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The algorithm for the dose of propofol that most frequently results in a CSM-level between 40 and 60.</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>General anesthesia titrated according to a cerebral state monitor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>General anesthesia titrated according to usual clinical criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective abdominal non-laparoscopic hysterectomy

          -  Age &gt; 18 years

          -  ASA physical status I-III

          -  Body Mass Index 30 or above

        Exclusion Criteria:

          -  Allergic towards propofol

          -  Daily consumption of benzodiazepines (more than at nighttime), opioids or amphetamine
             preoperatively.

          -  Disease with expected EEG-abnormality or impaired auditory function: Epilepsy,
             deafness, previous neurosurgery, previous or actual neurologic disease with neurologic
             deficit.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars S. Rasmussen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of anesthesia, 4231, Center of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesia, Juliane Marie Centre, Copenhagen University Hospital Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Anaesthesia, Copenhagen University Hospital Herlev</name>
      <address>
        <city>Herlev</city>
        <zip>DK-2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>Meyhoff CS, Henneberg SW, Jørgensen BG, Gätke MR, Rasmussen LS. Depth of anaesthesia monitoring in obese patients: a randomized study of propofol-remifentanil. Acta Anaesthesiol Scand. 2009 Mar;53(3):369-75. doi: 10.1111/j.1399-6576.2008.01872.x. Epub 2009 Jan 23.</citation>
    <PMID>19173688</PMID>
  </results_reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2005</study_first_submitted>
  <study_first_submitted_qc>December 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 26, 2005</study_first_posted>
  <last_update_submitted>October 15, 2009</last_update_submitted>
  <last_update_submitted_qc>October 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lars S. Rasmussen</name_title>
    <organization>Department of Anaesthesia, HOC, Copenhagen University Hospital, Rigshospitalet</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

